Imperial College London

Dr Matthew R. Lewis

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Director of Metabolic Profiling - COO NPC
 
 
 
//

Contact

 

matthew.lewis

 
 
//

Location

 

660Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Summary

As head of the section of Bioanalytical Chemistry, I oversee a talented and diverse team of experts responsible for the development and application of novel analytical methodology for global profiling and targeted analysis of small molecules, peptides, and beyond. Our principal application space is human biofluids and tissue extracts as well as the animal models and cell cultures needed to explore disease mechanisms in greater depth. Our favoured technology platforms include nuclear magnetic resonance (NMR), liquid chromatography mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS/MS). We are most active in the areas of:

  • Analytical method development
  • Technology development and refinement
  • Data extraction and pre-processing workflows
  • Data quality control and monitoring
  • Metabolite assignment and identification including structure elucidation

Together we work closely with clinicians, epidemiologists, and basic science researchers at Imperial to provide innovative and reliable solutions for metabolomics, lipidomics, and soon for proteomics.

As the Chief Operations Officer for the National Phenome Centre (NPC), I am responsible for operational management and delivery of a wide portfolio of research collaborations. Within the NPC, our focus is split between meeting the needs of high precision analysis demanded by large sample cohorts from molecular epidemiology studies, and those of studies involving smaller clinically derived cohorts analysed using both established and developing technologies.

Publications

Journals

Evans AM, O'Donovan C, Playdon M, et al., 2020, Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners., Metabolomics, Vol:16

Robinson O, Chadeau Hyam M, Karaman I, et al., 2020, Determinants of accelerated metabolomic and epigenetic ageing in a UK cohort, Aging Cell, Vol:19, ISSN:1474-9718, Pages:1-13

Takis P, Jimenez B, Sands C, et al., 2020, SMolESY: An efficient and quantitative alternative to on-instrument macromolecular ¹H-NMR signal suppression, Chemical Science, Vol:11, ISSN:2041-6520, Pages:6000-6011

Andreas NJ, Roy RB, Gomez-Romero M, et al., 2020, Performance of metabonomic serum analysis for diagnostics in paediatric tuberculosis, Scientific Reports, Vol:10, ISSN:2045-2322

Conference

Maciejewski M, Sands C, Nair N, et al., 2020, PREDICTION OF RESPONSE OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS USING SERUM LIPIDOMICS, Annual Conference of the British-Society-for-Rheumatology (BSR), OXFORD UNIV PRESS, ISSN:1462-0324

More Publications